CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan’s pricing of the EpiPen.
Terrific offer for my book, True North: Emerging Leader Edition on special sale for $3.99 for Kindle edition. Order Now